Metabolism of ketone bodies by skeletal muscle in starvation and uncontrolled diabetes

J. W. Bailey, M. W. Haymond, J. M. Miles

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Previous studies have suggested that skeletal muscle may be responsible for as much as 25% of ketone body (KB) production in poorly controlled diabetes. In the present studies, acetoacetate (AcAc) and β-hydroxybutyrate production was quantitated in the canine hindlimb from surgically placed arterial and venous catheters in conscious insulin-withdrawn diabetic (n = 5) and 4-day fasted (n = 7) dogs. A two-pool modeling technique, using simultaneous infusions of 13C acetoacetate and 14C β-hydroxybutyrate (βOHB) was employed to quantitate total body and hindlimb KB kinetics. Total KB production was 9.4 and 39.3 μmol · kg-1 · min-1 in the fasted and diabetic animals, respectively. Hindlimb KB production was negligible in both groups. The two-pool model estimates of hindlimb KB utilization were similar to the values obtained by an arterial-venous difference calculation. In conclusion, the hindlimb does not contribute to de novo synthesis of KBs in either fasted or diabetic dogs. Since species differences in KB metabolism occur, it is possible that muscle may be a site for KB production in humans.

Original languageEnglish (US)
Pages (from-to)1039-1043
Number of pages5
JournalMetabolism
Volume39
Issue number10
DOIs
StatePublished - 1990

Fingerprint

Ketone Bodies
Starvation
Skeletal Muscle
Hindlimb
Hydroxybutyrates
Dogs
Canidae
Catheters
Insulin
Muscles

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Metabolism of ketone bodies by skeletal muscle in starvation and uncontrolled diabetes. / Bailey, J. W.; Haymond, M. W.; Miles, J. M.

In: Metabolism, Vol. 39, No. 10, 1990, p. 1039-1043.

Research output: Contribution to journalArticle

Bailey, J. W. ; Haymond, M. W. ; Miles, J. M. / Metabolism of ketone bodies by skeletal muscle in starvation and uncontrolled diabetes. In: Metabolism. 1990 ; Vol. 39, No. 10. pp. 1039-1043.
@article{39e25a38ca35466084c6b76824891551,
title = "Metabolism of ketone bodies by skeletal muscle in starvation and uncontrolled diabetes",
abstract = "Previous studies have suggested that skeletal muscle may be responsible for as much as 25{\%} of ketone body (KB) production in poorly controlled diabetes. In the present studies, acetoacetate (AcAc) and β-hydroxybutyrate production was quantitated in the canine hindlimb from surgically placed arterial and venous catheters in conscious insulin-withdrawn diabetic (n = 5) and 4-day fasted (n = 7) dogs. A two-pool modeling technique, using simultaneous infusions of 13C acetoacetate and 14C β-hydroxybutyrate (βOHB) was employed to quantitate total body and hindlimb KB kinetics. Total KB production was 9.4 and 39.3 μmol · kg-1 · min-1 in the fasted and diabetic animals, respectively. Hindlimb KB production was negligible in both groups. The two-pool model estimates of hindlimb KB utilization were similar to the values obtained by an arterial-venous difference calculation. In conclusion, the hindlimb does not contribute to de novo synthesis of KBs in either fasted or diabetic dogs. Since species differences in KB metabolism occur, it is possible that muscle may be a site for KB production in humans.",
author = "Bailey, {J. W.} and Haymond, {M. W.} and Miles, {J. M.}",
year = "1990",
doi = "10.1016/0026-0495(90)90163-7",
language = "English (US)",
volume = "39",
pages = "1039--1043",
journal = "Metabolism: Clinical and Experimental",
issn = "0026-0495",
publisher = "W.B. Saunders Ltd",
number = "10",

}

TY - JOUR

T1 - Metabolism of ketone bodies by skeletal muscle in starvation and uncontrolled diabetes

AU - Bailey, J. W.

AU - Haymond, M. W.

AU - Miles, J. M.

PY - 1990

Y1 - 1990

N2 - Previous studies have suggested that skeletal muscle may be responsible for as much as 25% of ketone body (KB) production in poorly controlled diabetes. In the present studies, acetoacetate (AcAc) and β-hydroxybutyrate production was quantitated in the canine hindlimb from surgically placed arterial and venous catheters in conscious insulin-withdrawn diabetic (n = 5) and 4-day fasted (n = 7) dogs. A two-pool modeling technique, using simultaneous infusions of 13C acetoacetate and 14C β-hydroxybutyrate (βOHB) was employed to quantitate total body and hindlimb KB kinetics. Total KB production was 9.4 and 39.3 μmol · kg-1 · min-1 in the fasted and diabetic animals, respectively. Hindlimb KB production was negligible in both groups. The two-pool model estimates of hindlimb KB utilization were similar to the values obtained by an arterial-venous difference calculation. In conclusion, the hindlimb does not contribute to de novo synthesis of KBs in either fasted or diabetic dogs. Since species differences in KB metabolism occur, it is possible that muscle may be a site for KB production in humans.

AB - Previous studies have suggested that skeletal muscle may be responsible for as much as 25% of ketone body (KB) production in poorly controlled diabetes. In the present studies, acetoacetate (AcAc) and β-hydroxybutyrate production was quantitated in the canine hindlimb from surgically placed arterial and venous catheters in conscious insulin-withdrawn diabetic (n = 5) and 4-day fasted (n = 7) dogs. A two-pool modeling technique, using simultaneous infusions of 13C acetoacetate and 14C β-hydroxybutyrate (βOHB) was employed to quantitate total body and hindlimb KB kinetics. Total KB production was 9.4 and 39.3 μmol · kg-1 · min-1 in the fasted and diabetic animals, respectively. Hindlimb KB production was negligible in both groups. The two-pool model estimates of hindlimb KB utilization were similar to the values obtained by an arterial-venous difference calculation. In conclusion, the hindlimb does not contribute to de novo synthesis of KBs in either fasted or diabetic dogs. Since species differences in KB metabolism occur, it is possible that muscle may be a site for KB production in humans.

UR - http://www.scopus.com/inward/record.url?scp=0025147317&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025147317&partnerID=8YFLogxK

U2 - 10.1016/0026-0495(90)90163-7

DO - 10.1016/0026-0495(90)90163-7

M3 - Article

C2 - 2215251

AN - SCOPUS:0025147317

VL - 39

SP - 1039

EP - 1043

JO - Metabolism: Clinical and Experimental

JF - Metabolism: Clinical and Experimental

SN - 0026-0495

IS - 10

ER -